1-2 of 2
Liuqing Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury

Jinhua Tang, Yingfeng Shi, Na Liu, Liuqing Xu, Xiujuan Zang, Peibin Li, Juanlian Zhang, Xiaoqing Zheng, Andong Qiu, Shougang Zhuang
Journal: Clinical Science
Clin Sci (Lond) (2018) 132 (3): 339–359.
https://doi.org/10.1042/CS20171417
Published: 02 February 2018
View article titled, Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury
Open the PDF for Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury in another window
Includes: Supplementary data
Articles

Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease

Feng Liu, Li Wang, Hualin Qi, Jun Wang, Yi Wang, Wei Jiang, Liuqing Xu, Na Liu, Shougang Zhuang
Journal: Clinical Science
Clin Sci (Lond) (2017) 131 (16): 2125–2143.
https://doi.org/10.1042/CS20170134
Published: 24 July 2017
View article titled, Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease
Open the PDF for Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease in another window
Includes: Supplementary data